9 Best Drug Stocks to Buy According to Analysts

7. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best drug stocks to buy according to analysts. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) announced on April 20 the launch of Pimozide Tablets 1 mg and 2 mg, with the Pimozide Tablets being the generic version of the reference listed drug (RLD) Orap®. The company reported that the US annual sales for Pimozide Tablets totaled approximately $3.1 million, based on February 2026 moving annual total (MAT) IQVIA data. Nikhil Lalwani, President and Chief Executive Officer of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), stated that the company is excited to “bring limited competition products to market” while continuing to offer generic alternatives to its patients and customers.

In another development, ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg, and 300 mg on April 13. The company stated that its Carbamazepine Extended-Release Capsules are the generic version of the reference listed drug (RLD) Carbatrol®. It further reported that the US annual sales for Carbamazepine Extended-Release Capsules totaled approximately $65 million, based on February 2026 moving annual total (MAT) IQVIA data.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is a bio-pharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. The company’s operations are divided into the Generics, Established Brands, and Other, and Rare Disease segments.